Mark Bonyhadi
Director/Board Member at TC BIOPHARM (HOLDINGS) PLC
Net worth: - $ as of 30/11/2023
Mark Bonyhadi active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Director/Board Member | 22/02/2022 | - |
| Independent Dir/Board Member | 22/02/2022 | - |
Career history of Mark Bonyhadi
Former positions of Mark Bonyhadi
| Companies | Position | Start | End |
|---|---|---|---|
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | 01/12/2018 | 31/12/2022 |
| Private Equity Investor | 01/12/2018 | 31/12/2022 | |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Chief Tech/Sci/R&D Officer | - | 12/10/2021 |
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/01/2013 | 01/01/2018 |
Life Technologies Ltd.
 Life Technologies Ltd. BiotechnologyHealth Technology Life Technologies Ltd. engages in scientific and medical activities. The company was founded on May 13, 1983 and is headquartered in Paisley, the United Kingdom. | Corporate Officer/Principal | 01/01/2006 | 01/01/2013 |
| Xcyte Therapies, Inc. | Chief Tech/Sci/R&D Officer | 01/01/1997 | 30/03/2006 |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Chairman | - | - |
Training of Mark Bonyhadi
| The Reed Institute | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistics
International
| United States | 8 |
| United Kingdom | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Private companies | 6 |
|---|---|
| Xcyte Therapies, Inc. | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Life Technologies Ltd.
Life Technologies Ltd. BiotechnologyHealth Technology Life Technologies Ltd. engages in scientific and medical activities. The company was founded on May 13, 1983 and is headquartered in Paisley, the United Kingdom. | Health Technology |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |
- Stock Market
- Insiders
- Mark Bonyhadi
- Experience
